← Eichor
Study identifier: NCT07312760 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)

Condition: Advanced Cancer, Various, NOS  ·  Sponsor: Universitätsklinikum Hamburg-Eppendorf

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The psychological challenges faced by patients with incurable cancer and their caregivers include an uncertain future, fear of dying and uncontrollable suffering, grief, and loneliness. In a significant subgroup, this challenge is associated with significant fear and existential distress. This distress can manifest itself, for example, in the form of demoralization, a state of despair and hopelessness in which the possibilities for coping seem exhausted. Although open discussions about fears at the end of life are becoming increasingly important, little is known about how patients with high existential distress can best be supported to promote quality of life. The aim of the study is to test the effectiveness of the newly developed individual psychotherapy ORPHYS (ShORt-term psychodynamic psychotherapy in serious PHYSical illness) in reducing existential distress. To this end, a randomly selected half of the participants who receive ORPHYS treatment will be compared with a second group who receive the standard routine psycho-oncological treatment TAU (Treatment As Usual). The level of distress caused by demoralization will be used for the comparison. A total of 160 patients with advanced cancer will be included in the study. Due to improved treatment options, life expectancy for advanced cancer has increased significantly. This means that patients and their families must deal with the existential tension between uncertainty and a focus on life. The treatment is intended to …

This description comes directly from the study's public registry record.

Talk to the study team

Sigrun Vehling, PD Dr.  ·  +4940741056805  ·  s.vehling@uke.de

Rebecca Philipp, PhD  ·  +4940741056203  ·  r.philipp@uke.de

Always discuss trial participation with your own doctor first.

Locations (3)

Clinical Institute for Psychosomatic Medicine and Psychotherapy, University Medical Center DüsseldorfDüsseldorf, GermanyRecruiting
University Medical Center Hamburg-EppendorfHamburg, GermanyRecruiting
Psychosomatics, Psychotherapy and Psychooncology, Medicine II, University of WürzburgWürzburg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07312760